Bristol-Myers Squibb’s $14 Billion Acquisition of Karuna

Simpson Thacher & Bartlett is representing Karuna Therapeutics, Inc. in the transaction.Bristol-Myers Squibb Company (“BMS”, NYSE: BMY) announced its acquisition of Karuna Therapeutics, Inc. (“Karuna”) for $330 in…